Home › Amyloidosis › Massachusetts › Boston
Amyloidosis clinical trials in Boston, MA
11 studies for Amyloidosis are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RecruitingPhase 3
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
RecruitingPhase 3
- Clinical Trial Site, Boston
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RecruitingObservational study
- Clinical Trial Site, Boston
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Recruiting
- Massachusetts General Hospital, Boston
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RecruitingPhase 3
- Brigham and Women's Hospital, Boston
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RecruitingPhase 1/2
- Research Site, Boston
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
RecruitingPhase 1/2
- Boston Medical Center /ID# 255066, Boston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
Molecular Imaging of Primary Amyloid Cardiomyopathy
Recruiting
- Brigham and Womens' Hospital, Boston
About Amyloidosis
Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.
More about Amyloidosis on MedlinePlus
Amyloidosis trials in other cities
- New York City, NY10 studies
- Rochester, MN10 studies
- Dallas, TX9 studies
- Philadelphia, PA7 studies
- Durham, NC6 studies
- Houston, TX6 studies
- Baltimore, MD6 studies
- Portland, OR6 studies
- St. Louis, MO6 studies
- Washington, DC5 studies
- Cleveland, OH5 studies
- San Diego, CA5 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.